Literature DB >> 123043

Hereditary carnitine deficiency of muscle.

D H VanDyke, R C Griggs, W Markesbery, S Dimauro.   

Abstract

An eight-year-old boy with slowly progressive muscle weakness was found to have Oil red O positive vacuoles in predominanty type i muscle fibers. Subsequent studies demonstrated markedly reduced skeletal muscle carnitine (0.24 mumoles per gram; normal 1.64 to 3.34). Serum carnitine was normal. Although both parents were clinically normal, muscle carnitine levels were low in both (mother 0.60; father 0.90 mumoles). There was no clinical evidence of cardiac disease but the patient had ventricular hypertrophy by electrocardiography, vectorcardiography, and echocardiography. Treatment with prednisone resulted in clinical improvement but no change in muscle histology. Our studies suggest that the carnitine deficiency of muscle in this case may be due to impaired carnitine entry into muscle and that this form of disease can be inherited as an autosomal recessive disorder.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 123043     DOI: 10.1212/wnl.25.2.154

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  15 in total

1.  Deficiency of carnitine in cachectic cirrhotic patients.

Authors:  D Rudman; C W Sewell; J D Ansley
Journal:  J Clin Invest       Date:  1977-09       Impact factor: 14.808

2.  Carnitine deficiency: clinical, morphological, and biochemical observations in a fatal case.

Authors:  A G Engel; B Q Banker; R M Eiben
Journal:  J Neurol Neurosurg Psychiatry       Date:  1977-04       Impact factor: 10.154

Review 3.  Primary lipid cardiomyopathy.

Authors:  A Zimmermann; P Wyss; F Stocker
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

4.  Action of L-acetylcarnitine on different cerebral mitochondrial populations from hippocampus and striatum during aging.

Authors:  R F Villa; A Gorini
Journal:  Neurochem Res       Date:  1991-10       Impact factor: 3.996

5.  Autosomal recessive lipid storage myopathy (probable carnitine deficiency).

Authors:  C Almog; K Fried; R Reif; J Zieghelboim; G Lewinsohn
Journal:  J Med Genet       Date:  1979-12       Impact factor: 6.318

6.  [Carnitine deficiency: a treatable cause of cardiomyopathy in children (author's transl)].

Authors:  V Regitz; R J Hodach; A L Shug
Journal:  Klin Wochenschr       Date:  1982-04-15

7.  Successful carnitine treatment in a non-carnitine-deficient lipid storage myopathy.

Authors:  R C Sengers; J A Bakkeren; J M Trijbels; A M Stadhouders; G J Egberink; H J ter Laak; H J Jaspar
Journal:  Eur J Pediatr       Date:  1980-12       Impact factor: 3.183

Review 8.  l-Carnitine. A preliminary review of its pharmacokinetics, and its therapeutic use in ischaemic cardiac disease and primary and secondary carnitine deficiencies in relationship to its role in fatty acid metabolism.

Authors:  K L Goa; R N Brogden
Journal:  Drugs       Date:  1987-07       Impact factor: 9.546

9.  Fatal cases of lipid storage myopathy with carnitine deficiency.

Authors:  F Cornelio; S Di Donato; D Peluchetti; A Bizze; B Bertagnolio; A D'Angelo; U Wiesmann
Journal:  J Neurol Neurosurg Psychiatry       Date:  1977-02       Impact factor: 10.154

10.  "Carnitine deficient" myopathy and cardiomyopathy with fatal outcome.

Authors:  F Cornelio; S Di Donato; D Testa; M Mora; G Gori; D Peluchetti; M Rimoldi
Journal:  Ital J Neurol Sci       Date:  1980-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.